Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C25H35N3O |
| Molecular Weight | 393.5649 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)N1C=C2C[C@@H]3[C@H](C[C@H](CN3C)C(=O)NC4CCCCC4)C5=CC=CC1=C25
InChI
InChIKey=KEMOOQHMCGCZKH-JMUQELJHSA-N
InChI=1S/C25H35N3O/c1-16(2)28-15-17-13-23-21(20-10-7-11-22(28)24(17)20)12-18(14-27(23)3)25(29)26-19-8-5-4-6-9-19/h7,10-11,15-16,18-19,21,23H,4-6,8-9,12-14H2,1-3H3,(H,26,29)/t18-,21-,23-/m1/s1
| Molecular Formula | C25H35N3O |
| Molecular Weight | 393.5649 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Amesergide (previously known as LY237733) an ergoline derivative with highly selective 5-hydroxytryptamine (5-HT) antagonist activity and with a long duration of action. This drug was in phase II clinical trials for the treatment of erectile dysfunction and for the treatment of premature ejaculation. In addition, this drug participated in preclinical experiments to treat depression. All these studies were discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines. | 1994-02 |
|
| Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor. | 1993-03 |
Sample Use Guides
In Vivo Use Guide
Sources: https://adisinsight.springer.com/drugs/800001117
Unknown
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:20:53 GMT 2025
by
admin
on
Wed Apr 02 08:20:53 GMT 2025
|
| Record UNII |
EJL329H95R
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9821951
Created by
admin on Wed Apr 02 08:20:53 GMT 2025 , Edited by admin on Wed Apr 02 08:20:53 GMT 2025
|
PRIMARY | |||
|
Amesergide
Created by
admin on Wed Apr 02 08:20:53 GMT 2025 , Edited by admin on Wed Apr 02 08:20:53 GMT 2025
|
PRIMARY | |||
|
CHEMBL160293
Created by
admin on Wed Apr 02 08:20:53 GMT 2025 , Edited by admin on Wed Apr 02 08:20:53 GMT 2025
|
PRIMARY | |||
|
SUB05409MIG
Created by
admin on Wed Apr 02 08:20:53 GMT 2025 , Edited by admin on Wed Apr 02 08:20:53 GMT 2025
|
PRIMARY | |||
|
DTXSID8052851
Created by
admin on Wed Apr 02 08:20:53 GMT 2025 , Edited by admin on Wed Apr 02 08:20:53 GMT 2025
|
PRIMARY | |||
|
6937
Created by
admin on Wed Apr 02 08:20:53 GMT 2025 , Edited by admin on Wed Apr 02 08:20:53 GMT 2025
|
PRIMARY | |||
|
C169779
Created by
admin on Wed Apr 02 08:20:53 GMT 2025 , Edited by admin on Wed Apr 02 08:20:53 GMT 2025
|
PRIMARY | |||
|
100000087194
Created by
admin on Wed Apr 02 08:20:53 GMT 2025 , Edited by admin on Wed Apr 02 08:20:53 GMT 2025
|
PRIMARY | |||
|
DD-22
Created by
admin on Wed Apr 02 08:20:53 GMT 2025 , Edited by admin on Wed Apr 02 08:20:53 GMT 2025
|
PRIMARY | |||
|
121588-75-8
Created by
admin on Wed Apr 02 08:20:53 GMT 2025 , Edited by admin on Wed Apr 02 08:20:53 GMT 2025
|
PRIMARY | |||
|
EJL329H95R
Created by
admin on Wed Apr 02 08:20:53 GMT 2025 , Edited by admin on Wed Apr 02 08:20:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |